Earnings History Data for aTyr Pharma, Inc. (LIFE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

aTyr Pharma, Inc.

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-03-2024	AH		LIFE	aTyr Pharma, Inc.	94.87	-0.25	0.00	-0.26	aTyr Pharma GAAP EPS of -$0.25 misses by $0.01 [3/14/2024 4:04 PM]	1.99	0.37 (22.84%)	1.68	0.06 (3.70%)	1.08 - 2.70	1,356,816	670,000	8,681
aTyr Pharma GAAP EPS of -$0.25 misses by $0.01 [3/14/2024 4:04 PM]
09-08-2023	AH		LIFE	aTyr Pharma	107.00	-0.22	-0.27	0.00	aTyr Pharma GAAP EPS of -$0.22 beats by $0.05 [8/9/2023 5:33 PM]	1.96	0.0 (0.00%)	2.09	0.13 (6.63%)	1.55 - 4.28	183,868	220,000	1,198
aTyr Pharma GAAP EPS of -$0.22 beats by $0.05 [8/9/2023 5:33 PM]
09-03-2023	AH	4:00 PM ET (Mar 9)	LIFE	aTyr Pharma, Inc.	112.20	-0.26	-0.48	-0.31	aTyr Pharma GAAP EPS of -$0.26 beats by $0.22, revenue of $10.4M beats by $10.15M [3/9/2023 4:02 PM]	1.95	0.02 (1.04%)	2.00	0.07 (3.63%)	1.88 - 6.62	384,638	220,000	1,241
aTyr Pharma GAAP EPS of -$0.26 beats by $0.22, revenue of $10.4M beats by $10.15M [3/9/2023 4:02 PM]
10-11-2022	AH	4:00 PM ET (Nov 10)	LIFE	aTyr Pharma, Inc.	68.13	-0.46	-0.45	-0.42	aTyr Pharma GAAP EPS of -$0.46 in-line [11/10/2022 4:02 PM]	2.48	0.10 (4.20%)	2.21	-0.06 (-2.64%)	2.22 - 8.90	57,865	50,000	1,852
aTyr Pharma GAAP EPS of -$0.46 in-line [11/10/2022 4:02 PM] aTyr Pharma to Present at Upcoming Investor Conferences [Nov-10-22 08:00AM] aTyr Pharma Announces Publication of Positive Data from Phase 1b/2a Clinical Study of Efzofitimod for the Treatment of Pulmonary Sarcoidosis in the Journal CHEST [Nov-09-22 08:00AM] Atyr Pharma (LIFE) Reports Q3 Loss, Lags Revenue Estimates [Nov-10-22 05:15PM] aTyr Pharma Announces Third Quarter 2022 Results and Provides Corporate Update [Nov-10-22 04:00PM]
15-08-2022	AH	4:00 PM ET (Aug 15)	LIFE	aTyr Pharma, Inc.	93.71	-0.44	-0.43	-0.64	aTyr Pharma GAAP EPS of -$0.44 in-line [8/15/2022 4:02 PM]	4.15	0.51 (14.01%)	4.07	0.43 (11.81%)	2.60 - 13.10	983,469	140,000	395,250
aTyr Pharma GAAP EPS of -$0.44 in-line [8/15/2022 4:02 PM] aTyr pharma stock rises 15% after Q2 results; efzofitimod phase 3 trial enrollment on track [8/16/2022 12:44 PM] aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Aug-12-22 04:05PM]
09-05-2022	AH	4:00 PM ET (May 9)	LIFE	aTyr Pharma, Inc.	115.07	-0.44	-0.34	-0.51	aTyr Pharma GAAP EPS of -$0.44 misses by $0.11 [5/9/2022 4:06 PM]	3.52	-0.07 (-1.95%)	3.60	0.01 (0.28%)	3.45 - 13.10	146,438	120,621	500
aTyr Pharma GAAP EPS of -$0.44 misses by $0.11 [5/9/2022 4:06 PM] Love Hemp Group PLC Announces Update Regarding Trading Suspension [May-09-22 02:40AM] aTyr Pharma Announces First Quarter 2022 Results and Provides Corporate Update [May-09-22 04:00PM] Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates [May-09-22 05:15PM] aTyr Pharma to Present at Upcoming Investor Conferences in May [May-10-22 08:00AM] Is aTyr Pharma, Inc. (NASDAQ:LIFE) Popular Amongst Institutions? [May-10-22 02:00PM]
14-03-2022	AH	4:00 PM ET (Mar 14)	LIFE	aTyr Pharma, Inc.	146.46	-0.31	-0.24	-0.47	aTyr Pharma GAAP EPS of -$0.31 misses by $0.03 [3/14/2022 4:06 PM]	4.73	-0.02 (-0.40%)	4.71	-0.04 (-0.84%)	3.50 - 13.10	87,427	100,000	15,543
aTyr Pharma GAAP EPS of -$0.31 misses by $0.03 [3/14/2022 4:06 PM] aTyr Pharma files for $200M mixed shelf offering [3/15/2022 5:56 PM] aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update [Mar-14-22 04:00PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	LIFE	aTyr Pharma, Inc.	233.24	-0.42	-0.53	-0.68	aTyr Pharma EPS beats by $0.15 [11/10/2021 4:23 PM]	8.67	0.36 (4.36%)	8.30	-0.01 (-0.12%)	3.12 - 13.10	347,125	190,000	5,003
aTyr Pharma EPS beats by $0.15 [11/10/2021 4:23 PM] aTyr Pharma Presents Research Demonstrating Effects of Novel NRP2-Targeting Antibody, ATYR2810, on Tumor Associated Macrophages at the Society for Immunotherapy of Cancer Annual Meeting [Nov-09-21 08:05AM] aTyr Pharma Announces Third Quarter 2021 Results and Provides Corporate Update [Nov-10-21 04:00PM] Atyr Pharma (LIFE) Reports Q3 Loss, Misses Revenue Estimates [Nov-10-21 05:15PM]
10-08-2021	AH	4:05 PM ET (Aug 10)	LIFE	aTyr Pharma, Inc.	75.50	-0.64	-0.46	-0.69	aTyr Pharma EPS misses by $0.15 [8/10/2021 4:22 PM]	4.83	0.03 (0.62%)	4.80	0.0 (0.00%)	2.93 - 8.33	184,164	140,000	3,604
aTyr Pharma EPS misses by $0.15 [8/10/2021 4:22 PM] aTyr Pharma Announces Two Abstracts for ATYR1923 Accepted for Presentation at the European Respiratory Society International Congress [Aug-09-21 08:00AM] aTyr Pharma Announces Expansion of Research Collaboration with The Ohio State University [Aug-10-21 08:00AM] aTyr Pharma Announces Second Quarter 2021 Results and Provides Corporate Update [Aug-10-21 04:00PM] Atyr Pharma (LIFE) Reports Q2 Loss, Lags Revenue Estimates [Aug-10-21 05:15PM]
13-05-2021	AH	4:05 PM ET (May 13)	LIFE	aTyr Pharma, Inc.	61.64	-0.51	-0.34	0.25	aTyr Pharma EPS misses by $0.19 [5/13/2021 4:29 PM]	3.68	0.06 (1.66%)	3.55	-0.07 (-1.93%)	2.93 - 8.33	278,227	220,000	13,975
aTyr Pharma EPS misses by $0.19 [5/13/2021 4:29 PM] aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Achieve Milestones for First Year of Government Grant to Develop Bispecific Antibody Platform [May-12-21 08:00AM] aTyr Pharma, Inc. to Host Earnings Call [May-13-21 03:15PM] aTyr Pharma Announces First Quarter 2021 Results and Provides Corporate Update [May-13-21 04:05PM] Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates [May-13-21 05:20PM]
23-03-2021	AH	4:05 PM ET (Mar 23)	LIFE	aTyr Pharma, Inc.	57.14	-0.47	-0.82	-1.54	aTyr Pharma EPS beats by $0.35, beats on revenue [3/23/2021 4:14 PM]	4.66	-0.26 (-5.39%)	5.40	0.48 (9.76%)	2.40 - 8.33	1,493,699	3,740,000	181,359
aTyr Pharma EPS beats by $0.35, beats on revenue [3/23/2021 4:14 PM] aTyr Pharma, Inc. to Host Earnings Call [Mar-23-21 03:15PM] aTyr Pharma Announces Fourth Quarter and Full Year 2020 Results and Provides Corporate Update [Mar-23-21 04:05PM] aTyr Pharma: Q4 Earnings Insights [Mar-23-21 04:46PM] aTyr Pharma Pops 6% On Lower-Than-Feared Quarterly Loss, Revenue Outperforms [Mar-24-21 08:16AM]
12-11-2020	AH	4:00 PM ET (Nov 12)	LIFE	aTyr Pharma, Inc.	30.92	-0.68	-0.74	-1.47	aTyr Pharma EPS beats by $0.06, beats on revenue [11/12/2020 4:08 PM]	3.40	0.04 (1.19%)	3.36	0.0 (0.00%)	2.13 - 7.62	104,459	56,993	1,310

13-08-2020	AH	4:05 PM ET (Aug 13)	LIFE	aTyr Pharma, Inc.	35.76	-0.69	-0.73	-1.80	aTyr Pharma EPS beats by $0.04, misses on revenue [8/13/2020 4:09 PM]	3.76	-0.15 (-3.84%)	3.75	-0.16 (-4.09%)	2.13 - 7.62	49,830	89,562	1,470

12-05-2020	AH	4:00 PM ET (May 12)	LIFE	aTyr Pharma, Inc.	36.47	0.25	-0.18	-2.52	aTyr Pharma EPS beats by $0.65, beats on revenue [5/12/2020 4:08 PM]	3.71	-0.16 (-4.13%)	4.00	0.13 (3.36%)	2.13 - 7.71	187,353	90,795	11,689